Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease

Although sitafloxacin (STFX) is known to have a favorable minimum inhibitory concentration for Mycobacterium avium, few studies have evaluated the clinical efficacy of an STFX-containing regimen for pulmonary M avium complex (MAC) disease. To evaluate the clinical efficacy of STFX-containing regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kohei, Fujita, Masaki, Ito, Yutaka, Hirai, Toyohiro, Mio, Tadashi, Watanabe, Kentaro, Mishima, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047425/
https://www.ncbi.nlm.nih.gov/pubmed/27704005
http://dx.doi.org/10.1093/ofid/ofw147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047425/
https://www.ncbi.nlm.nih.gov/pubmed/27704005
http://dx.doi.org/10.1093/ofid/ofw147

Ejemplares similares